Manganese- and Platinum-Driven Oxidative and Nitrosative Stress in Oxaliplatin-Associated CIPN with Special Reference to Ca4Mn(DPDP)5, MnDPDP and DPDP von Karlsson, Jan Olof G., Jynge, Per

Volltext

Comments on “Clinically relevant therapeutic approaches against acetaminophen (APAP) hepatotoxicity and acute liver failure” von Karlsson, Jan Olof G., Jynge, Per

Volltext

Exacerbated Neuropathy in POLAR A and M Trials Due to Redox Interaction of PledOx-Associated Mn2+ and Oxaliplatin-Associated Pt2 von Karlsson, Jan Olof G., Jynge, Per, Ignarro, Louis J.

Volltext

Mangafodipir a Selective Cytoprotectant — with Special Reference to Oxaliplatin and Its Association to Chemotherapy-Induced Peripheral Neuropathy (CIPN) von Karlsson, Jan Olof G., Andersson, Rolf GG, Jynge, Per

Volltext

May Mangafodipir or Other SOD Mimetics Contribute to Better Care in COVID-19 Patients? von Karlsson, Jan Olof G, Jynge, Per, Ignarro, Louis J

Volltext

Manganese- and Platinum-Driven Oxidative and Nitrosative Stress in Oxaliplatin-Associated CIPN with Special Reference to Ca 4 Mn(DPDP) 5 , MnDPDP and DPDP von Karlsson, Jan Olof G, Jynge, Per

Volltext

The Damaging Outcome of the POLAR Phase III Trials Was Due to Avoidable Time-Dependent Redox Interaction between Oxaliplatin and PledOx von Karlsson, Jan Olof G, Jynge, Per, Ignarro, Louis J

Volltext

Letter in response to: "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for para... von Karlsson, Jan Olof G, Jynge, Per, Lundström, Ingemar, Ignarro, Louis J

Volltext

Comment on “Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity” Antioxidants... von Stehr, Jan Eric, Lundström, Ingemar, Karlsson, Jan Olof G.

Volltext

Evidence that fodipir (DPDP) binds neurotoxic Pt2+ with a high affinity: An electron paramagnetic resonance study von Stehr, Jan Eric, Lundström, Ingemar, Karlsson, Jan Olof G.

Volltext

Calmangafodipir [Ca4Mn(DPDP)5], mangafodipir (MnDPDP) and MnPLED with special reference to their SOD mimetic and therapeutic properties von Karlsson, Jan Olof G., Ignarro, Louis J., Lundström, Ingemar, Jynge, Per, Almén, Torsten

Volltext

Is it possible to draw firm conclusions from the PLIANT trial? von Karlsson, Jan Olof G, Jynge, Per

Volltext

Evidence that fodipir (DPDP) binds neurotoxic Pt 2+ with a high affinity: An electron paramagnetic resonance study von Stehr, Jan Eric, Lundström, Ingemar, Karlsson, Jan Olof G

Volltext

Superior Therapeutic Index of Calmangafodipir in Comparison to Mangafodipir as a Chemotherapy Adjunct von Karlsson, Jan Olof G, Kurz, Tino, Flechsig, Susanne, Näsström, Jacques, Andersson, Rolf G.G

Volltext

Exacerbated Neuropathy in POLAR A and M Trials Due to Redox Interaction of PledOx-Associated Mn[sup.2+] and Oxaliplatin-Associated Pt[sup.2+] von Karlsson, Jan Olof G, Jynge, Per, Ignarro, Louis J

Volltext

Gastrointestinal AEs seen in the POP trial due to SOD mimetic activity of calmangafodipir? von Karlsson, Jan Olof G.

Volltext

First Clinical Experience with the Magnetic Resonance Imaging Contrast Agent and Superoxide Dismutase Mimetic Mangafodipir as an Adjunct in Cancer Chemotherapy—A Translational Stud... von Karlsson, Jan Olof G, Adolfsson, Karin, Thelin, Bo, Jynge, Per, Andersson, Rolf G.G, Falkmer, Ursula G

Volltext

Effects of MnDPDP and ICRF-187 on Doxorubicin-Induced Cardiotoxicity and Anticancer Activity von Kurz, Tino, Grant, Derek, Andersson, Rolf G.G, Towart, Robertson, De Cesare, Michelandrea, Karlsson, Jan Olof G

Volltext

Manganese- and Platinum-Driven Oxidative and Nitrosative Stress in Oxaliplatin-Associated CIPN with Special Reference to Ca[sub.4]Mn[sub.5], MnDPDP and DPDP von Karlsson, Jan Olof G, Jynge, Per

Volltext

Antioxidant activity of mangafodipir is not a new finding von Karlsson, Jan Olof G

Volltext